STX2 and hemolytic-uremic syndrome: Stx1a, Stx2a, Stx2c, and Stx2d are significantly associated with severe clinical outcomes such as hemorrhagic colitis (HC) and HUS, whereas other subtypes are linked to mild symptoms [9,10].